Long Noncoding RNA Cardiac Physiological Hypertrophy–Associated Regulator Induces Cardiac Physiological Hypertrophy and Promotes Functional Recovery After Myocardial Ischemia-Reperfusion Injury
- 27 July 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (4) , 303-317
Abstract
Background: Exercise training's benefits in cardiovascular system have been well accepted, however, the underlying mechanism remains to be explored. Here, we report the initial functional characterization of an exercise-induced cardiac physiological hypertrophy associated novel lncRNA. Methods: Using lncRNA microarray profiling, we identified lncRNAs in contributing the modulation of exercise-induced cardiac growth that we termed Cardiac Physiological hypertrophy associated regulator (CPhar). Mice with Adeno-associated virus serotype 9 (AAV9) driving CPhar overexpression and knockdown were used in in-vivo experiments. Swim training was used to induce physiological cardiac hypertrophy in mice and ischemia reperfusion injury (IR/I) surgery was conducted to investigate the protective effects of CPhar in mice. To investigate the mechanisms of CPhar's function, we performed various analysis including RTqPCR, western blot, histology, cardiac function (by echocardiography), functional rescue experiments, mass spectrometry, in vitro RNA transcription, RNA pull down, RNA immunoprecipitation, chromatin immunoprecipitation assay, luciferase reporter assay, and coimmunoprecipitation assays. Results: We screened the lncRNAs in contributing the modulation of exercise-induced cardiac growth via lncRNA microarray profiling and found that CPhar was increased with exercise and was necessary for exercise-induced physiological cardiac growth. Gain- and loss- of function of CPhar regulated the expression of proliferation markers, hypertrophy, and apoptosis in cultured neonatal mouse cardiomyocytes (NMCMs). Overexpression of CPhar prevented myocardial ischemia reperfusion injury and cardiac dysfunction in vivo. We identified DDX17 as a binding partner of CPhar in regulating CPhar downstream factor ATF7 by sequestering C/EBPβ. Conclusions: Our study of this lncRNA CPhar provides new insights into the regulation of exercise-induced cardiac physiological growth, demonstrating the cardioprotective role of CPhar in the heart, as well as expanding our mechanistic understanding of lncRNA function.Keywords
This publication has 39 references indexed in Scilit:
- A long noncoding RNA protects the heart from pathological hypertrophyNature, 2014
- The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489Circulation Research, 2014
- CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulationNature Communications, 2014
- The Oxygen-Rich Postnatal Environment Induces Cardiomyocyte Cell-Cycle Arrest through DNA Damage ResponseCell, 2014
- Surgical models for cardiac regeneration in neonatal miceNature Protocols, 2014
- Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage CommitmentCell, 2013
- Mammalian heart renewal by pre-existing cardiomyocytesNature, 2012
- C/EBPβ Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac RemodelingCell, 2010
- Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cellsGenes & Development, 2007
- The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressorThe EMBO Journal, 2005